Health and social care research helps us learn about why we become ill and what we can do to stay well. It advances our knowledge so that we can find new treatments, change the way we deliver care, prevent illness and improve the environment, health and wellbeing of local populations.
We support research that benefits people who use our services and the communities we serve. We have studies for children and young people, dementia, substance misuse, eating disorders, learning disabilities and mental health.
While often more subtle than positive and negative symptoms, cognitive impairment associated with schizophrenia (CIAS) affects nearly everyone living with the condition. Currently, there are no approved drugs to treat these cognitive symptoms. Tally is a new clinical trial that aims to understand if an investigational drug could be effective in impacting the lives of people with schizophrenia who experience cognitive difficulties.
If you have a diagnosis of schizophrenia and are aged 18 to 55, or know someone is and who might benefit from this research please get in touch.
Participants will be randomly assigned to receive either an active drug or placebo. During the duration of the trial (20 weeks) they will be required to visit the clinic about every 2 weeks to complete physical and cognitive tests. All travel and food expenses are covered.
If you are interested in the study or would like more information please contact the Research and Development Department, on 01932 722247 or email email@example.com